| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $7.4M | +12.6% |
| Cost of Revenue | $3.9M | +19.4% |
| Gross Profit | $3.5M | +6.0% |
| R&D Expense | $546K | -18.4% |
| SG&A Expense | $3.2M | -12.0% |
| Operating Income | -$940K | +87.3% |
| Pre-tax Income | -$899K | +87.8% |
| Income Tax | $5K | +101.3% |
| Net Income | -$904K |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6K | -99.4% |
| Short-term Investments | $250K | — |
| Accounts Receivable | $732K | -12.2% |
| Current Assets | $2.6M | +4.7% |
| Total Assets | $4.0M | -0.8% |
| Current Liabilities | $1.2M | +30.7% |
| Total Liabilities | $1.2M | +30.7% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $307K | +115.8% |
| Capital Expenditures | $15K | -53.1% |
| Investing Cash Flow | -$265K | -728.1% |
| Financing Cash Flow | -$50K | — |
| Free Cash Flow | $292K | +114.8% |
| +87.1% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Stockholders' Equity |
| $2.7M |
| -10.8% |